General Information of Drug Therapeutic Target (DTT) (ID: TTV1C0Z)

DTT Name Neuropeptide S receptor (NPSR)
Synonyms
PGR14; Gprotein coupled receptor for asthma susceptibility; Gprotein coupled receptor PGR14; Gprotein coupled receptor 154; GPRA; GPR154; G-protein coupled receptor for asthma susceptibility; G-protein coupled receptor PGR14; G-protein coupled receptor 154
Gene Name NPSR1
DTT Type
Patented-recorded target
[1]
BioChemical Class
GPCR rhodopsin
UniProt ID
NPSR1_HUMAN
TTD ID
T20958
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MPANFTEGSFDSSGTGQTLDSSPVACTETVTFTEVVEGKEWGSFYYSFKTEQLITLWVLF
VFTIVGNSVVLFSTWRRKKKSRMTFFVTQLAITDSFTGLVNILTDINWRFTGDFTAPDLV
CRVVRYLQVVLLYASTYVLVSLSIDRYHAIVYPMKFLQGEKQARVLIVIAWSLSFLFSIP
TLIIFGKRTLSNGEVQCWALWPDDSYWTPYMTIVAFLVYFIPLTIISIMYGIVIRTIWIK
SKTYETVISNCSDGKLCSSYNRGLISKAKIKAIKYSIIIILAFICCWSPYFLFDILDNFN
LLPDTQERFYASVIIQNLPALNSAINPLIYCVFSSSISFPCREQRSQDSRMTFRERTERH
EMQILSKPEFI
Function
Promotes mobilization of intracellular Ca(2+) stores. Inhibits cell growth in response to NPS binding. Involved in pathogenesis of asthma and other IgE-mediated diseases. G-protein coupled receptor for neuropeptide S (NPS).
KEGG Pathway
Neuroactive ligand-receptor interaction (hsa04080 )
Reactome Pathway
G alpha (q) signalling events (R-HSA-416476 )
G alpha (s) signalling events (R-HSA-418555 )
ADORA2B mediated anti-inflammatory cytokines production (R-HSA-9660821 )
Peptide ligand-binding receptors (R-HSA-375276 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
26 Patented Agent(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivative 1 DMCISHW N. A. N. A. Patented [1]
4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivative 2 DMPTRQD N. A. N. A. Patented [1]
4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivative 3 DMFOBM9 N. A. N. A. Patented [1]
4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivative 4 DM6MCBU N. A. N. A. Patented [1]
Imidazo pyridine derivative 4 DM3YMHP N. A. N. A. Patented [1]
Imidazo pyridine derivative 5 DMOVJ35 N. A. N. A. Patented [1]
Imidazo pyridine derivative 6 DMG6W3O N. A. N. A. Patented [1]
Indandione derivative 1 DMA6BCH N. A. N. A. Patented [1]
Indandione derivative 2 DMVR04K N. A. N. A. Patented [1]
Indandione derivative 3 DM0TURE N. A. N. A. Patented [1]
Indanone and indandione derivative 1 DMQPTEJ N. A. N. A. Patented [1]
Oxazolo[3,4-a]pyrazine derivative 1 DMPZ81S N. A. N. A. Patented [1]
Oxazolo[3,4-a]pyrazine derivative 2 DM28E0A N. A. N. A. Patented [1]
Oxazolo[3,4-a]pyrazine derivative 3 DM1LPKH N. A. N. A. Patented [1]
Oxazolo[3,4-a]pyrazine derivative 4 DM1B74D N. A. N. A. Patented [1]
Oxazolo[3,4-a]pyrazine derivative 5 DMC5G76 N. A. N. A. Patented [1]
Oxazolo[3,4-a]pyrazine derivative 6 DM5DC9A N. A. N. A. Patented [1]
Oxazolo[3,4-a]pyrazine derivative 7 DMEX5VK N. A. N. A. Patented [1]
PMID27788040-Compound-5 DMHPK31 N. A. N. A. Patented [1]
PMID27788040-Compound-5a DMW3X1I N. A. N. A. Patented [1]
PMID27788040-Compound-5b DMPQKXR N. A. N. A. Patented [1]
PMID27788040-Compound-5c DMK72JS N. A. N. A. Patented [1]
PMID27788040-Compound-6 DMHX8OF N. A. N. A. Patented [1]
PMID27788040-Compound-6a DM4QA6X N. A. N. A. Patented [1]
PMID27788040-Compound-6b DMD3U96 N. A. N. A. Patented [1]
PMID27788040-Compound-6c DMNRU35 N. A. N. A. Patented [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 26 Patented Agent(s)
3 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
PI1 DM68JNY Discovery agent N.A. Investigative [2]
QA1 DM26GBV Discovery agent N.A. Investigative [3]
SHA 68 DMW7E32 Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------

References

1 Neuropeptide S receptor ligands: a patent review (2005-2016).Expert Opin Ther Pat. 2017 Mar;27(3):347-362.
2 Tricyclic imidazole antagonists of the Neuropeptide S Receptor. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4704-8.
3 Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4700-3.
4 Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. Peptides. 2010 May;31(5):915-25.